The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children ...

Doctors prescribe Humulin R for adults and children with either type 1 ... insulin per mL The U-100 strength of Humulin R comes in 3-milliliter (mL) and 10-mL vials. You’ll use insulin syringes ...

Insulin allows cells to absorb and use glucose. In people with insulin resistance, the cells are unable to use insulin effectively. Insulin resistance occurs when cells in the body do not respond ...

This Amendment was never published, its content has been included in the published Rec. ITU-T G.8271.1/Y.1366.1 (2013). Superseded ...

This ineffective use of insulin causes high blood sugar, which is the main marker of diabetes. The two main types of diabetes are type 1 and type 2 ... Gastrointestinal manifestations of diabetes. In: ...

Diabetes Care. 2025;48(Supplement_1):S86-S127. doi:10.2337/dc25-S005 National Institute of Diabetes and Digestive and Kidney Diseases. Insulin resistance and prediabetes. American Diabetes Association ...

In this study, significantly more patients in the insulin pen group prepared and self-injected at least one dose of insulin compared with the vial and syringe group. Patients with newly diagnosed ...

Initial results of Sana Biotechnology’s new gene-editing technique demonstrate that transplanted islet cells successfully produced insulin in one individual with type 1 diabetes – without the need for ...